Ipratropium Interactions
There are 103 drugs known to interact with ipratropium, along with 3 disease interactions. Of the total drug interactions, 102 are moderate, and 1 is minor.
- View all 103 medications that may interact with ipratropium
- View ipratropium disease interactions (3)
Most frequently checked interactions
View interaction reports for ipratropium and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Lasix (furosemide)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- ProAir HFA (albuterol)
- Protonix (pantoprazole)
- Singulair (montelukast)
- Spiriva (tiotropium)
- Symbicort (budesonide / formoterol)
- Synthroid (levothyroxine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Ipratropium disease interactions
There are 3 disease interactions with ipratropium which include:
Report options
QR code containing a link to this page
More about ipratropium
- ipratropium consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (21)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergic bronchodilators
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.